Deep Vein Thrombosis
📧 Sign up to get email alerts when something new happens for Deep Vein Thrombosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2008-03-04Clinical Trial Update: Treatment for Blood Clots in the Veins of the Legs [Phase 1]
A Phase 1 study evaluating a treatment for blood clots in leg veins has completed. Conditions include deep vein thrombosis, pulmonary emboli…
-
CLINICAL_TRIALS trial_result · 2008-01-09Clinical Trial Update: Comparison Between Two Optional IVC Filters Regardind Ease of Use,Complications and Outcome [NA]
This clinical trial update compares two optional inferior vena cava filters for ease of use, complications, and outcomes, particularly in pa…
-
FDA approval · 2007-12-14FDA Approved: HEPARIN SODIUM — Supplemental Application (Civica, Inc.)
FDA approved Civica, Inc.'s supplemental application for HEPARIN SODIUM. This action approves a supplemental NDA related to the product (NDA…
-
CLINICAL_TRIALS trial_result · 2007-11-01Clinical Trial Update: EVENT: Hydrotherapy and Deep Venous Thrombosis [Phase 3]
A Phase 3 clinical trial evaluating hydrotherapy for deep vein thrombosis was terminated.
-
CLINICAL_TRIALS trial_result · 2007-10-10Clinical Trial Update: Evaluation of PD 0348292 for Preventing Blood Clots in the Lungs or Deep Leg Veins of Patients After Knee Surgery [Phase 2]
Pfizer completed a Phase 2 trial evaluating PD 0348292 for preventing venous thromboembolism (deep vein thrombosis and pulmonary embolism) a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2007-07-11FDA Approved: WARFARIN SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Warfarin Sodium from Teva Pharmaceuticals USA, Inc. for the generic product under the ANDA.
-
CLINICAL_TRIALS research · 2007-06-11Clinical Trial Update: Modeling Genotype and Other Factors to Enhance the Safety of Coumadin Prescribing [NA]
This clinical trial update discusses modeling genotype and other factors to improve the safety of warfarin (Coumadin) prescribing. It covers…
-
CLINICAL_TRIALS trial_result · 2007-05-23Clinical Trial Update: Sonography Outcomes Assessment Program for Lower Extremity Deep Venous Thrombosis
This document provides an update on the clinical trial evaluating sonography outcomes for lower extremity deep vein thrombosis. The trial, s…
-
CLINICAL_TRIALS trial_result · 2007-02-27Clinical Trial Update: The D-KAF (Dalteparin in Knee-to-Ankle Fracture) Trial [Phase 4]
A Phase 4 trial evaluating dalteparin for patients with knee-to-ankle fractures has completed, studying the risks of deep vein thrombosis an…
-
CLINICAL_TRIALS trial_result · 2007-02-22Clinical Trial Update: Residual Vein Thrombosis Establishes the Optimal Duration of Oral Anticoagulants [Phase 4]
Phase 4 trial findings suggest a strategy to determine the optimal duration of oral anticoagulants for deep vein thrombosis based on residua…
-
CLINICAL_TRIALS trial_result · 2007-02-09Clinical Trial Update: Trial of the Effect of Low-Molecular-Weight Heparin (LMWH) Versus Warfarin on Mortality in the Long-Term Treatment of Proximal Deep Vein Thrombosis (DVT) (Main LITE Study) [Phase 4]
The Main LITE study comparing low-molecular-weight heparin to warfarin for long-term treatment of proximal deep vein thrombosis has complete…
-
CLINICAL_TRIALS trial_result · 2007-02-09Clinical Trial Update: Assessment of Long-Term Out-of-Hospital Treatment of Patients With Proximal Deep Vein Thrombosis (DVT) Using Low-Molecular-Weight Heparin (LMWH) Versus LMWH Followed by Warfarin [Phase 4]
A Phase 4 trial comparing long-term out-of-hospital treatment of proximal deep vein thrombosis with low-molecular-weight heparin alone versu…
-
FDA approval · 2007-01-12FDA Approved: ENOXAPARIN SODIUM — Supplemental Application (Sanofi-Aventis U.S. LLC)
FDA approved a supplemental application for ENOXAPARIN SODIUM submitted by Sanofi-Aventis U.S. LLC.
-
CLINICAL_TRIALS trial_result · 2006-11-22Clinical Trial Update: Ontario ICU Clinical Best Practices Demonstration Project [NA]
A completed Ontario ICU best-practices demonstration project evaluating strategies to reduce complications such as ventilator-associated pne…
-
CLINICAL_TRIALS trial_result · 2006-11-17Clinical Trial Update: PROphylaxis for ThromboEmbolism in Critical Care Trial (PROTECT Pilot) [Phase 3]
Phase 3 PROTECT Pilot trial update on prophylaxis for thromboembolism in critically ill patients; the trial status is completed.
-
FDA approval · 2006-10-04FDA Approved: HEPARIN SODIUM — Supplemental Application (Civica, Inc.)
The FDA approved Civica, Inc.'s supplemental application for Heparin Sodium. This action updates the product labeling as part of the NDA 017…
-
CLINICAL_TRIALS trial_result · 2006-10-04Clinical Trial Update: Failed Retrieval of Inferior Vena Cava (IVC) Filters: Long-Term Outcomes
This clinical trial update discusses long-term outcomes related to inferior vena cava (IVC) filters after retrieval failure, with the trial …
-
CLINICAL_TRIALS trial_result · 2006-09-08Clinical Trial Update: D-Dimer Vs Serial Compression Ultrasound Study [Phase 3]
A Phase 3 trial comparing D-Dimer testing with serial compression ultrasound in deep vein thrombosis has completed.
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: 3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PE [Phase 4]
Phase 4 trial comparing 3 months versus 6 months of anticoagulation in patients with deep vein thrombosis and/or pulmonary embolism; the stu…
-
CLINICAL_TRIALS trial_result · 2006-06-20Clinical Trial Update: ActiveCare+SFT Hemodynamic Profile Compare to SCD Express in Ventilated Patients
A clinical trial update comparing the ActiveCare+SFT Hemodynamic Profile device to SCD Express in ventilated patients to evaluate hemodynami…
-
FDA approval · 2006-05-05FDA Approved: JANTOVEN — Supplemental Application (Upsher-Smith Laboratories, LLC)
FDA approved a supplemental application for JANTOVEN (warfarin sodium) from Upsher-Smith Laboratories, LLC.
-
CLINICAL_TRIALS trial_result · 2006-05-03Clinical Trial Update: Canadian Pulmonary Embolism Diagnosis Study (CANPEDS) [Phase 3]
Phase 3 CANPEDS trial for suspected pulmonary embolism and deep vein thrombosis was terminated.